Core Laboratories
CLB
186 hedge funds and large institutions have $868M invested in Core Laboratories in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 72 reducing their positions, and 19 closing their positions.
1,230% more call options, than puts
Call options by funds: $5.85M | Put options by funds: $440K
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
4% more funds holding
Funds holding: 178 → 186 (+8)
1.62% more ownership
Funds ownership: 103.64% → 105.26% (+1.6%)
25% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 72
25% less capital invested
Capital invested by funds: $1.16B → $868M (-$292M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$15.5M |
| 2 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$4.85M |
| 3 |
RA
Royce & Associates
New York
|
+$4.53M |
| 4 |
BlackRock
New York
|
+$4.46M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.83M |
Top Sellers
| 1 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$10.2M |
| 2 |
FAM
Fred Alger Management
New York
|
-$6.18M |
| 3 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
-$4.9M |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$3.32M |
| 5 |
VanEck Associates
New York
|
-$2.45M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCPG
201
Trivant Custom Portfolio Group
San Diego,
California
| – | -$20.8K | -867 | Closed |
|
|
FCA
202
FinTrust Capital Advisors
Greenville,
South Carolina
| – | -$2.47K | -103 | Closed |
|
|
BAAM
203
Baker Avenue Asset Management
San Francisco,
California
| – | -$1.18K | -49 | Closed |
|
204
Group One Trading
Chicago,
Illinois
| – | -$564 | -28 | Closed |
|
|
AW
205
Avion Wealth
The Woodlands,
Texas
| – | +$544 | +27 | New |
|
CLB Hedge Fund Activity: Q4 2023 in Review
186 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2023, worth a combined $868M — down 25% from $1.16B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new CLB positions and 19 closed out — a net gain of 9 holders — while 54 added to existing stakes and 72 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $15.5M. The largest seller was State Farm Mutual Automobile Insurance, exiting entirely with an estimated $10.2M sold.
- 186 institutional investors held Core Laboratories (CLB) as of Q4 2023, up from 178 in Q3 2023.
- Funds reported $868M of Core Laboratories stock for Q4 2023, down 25% quarter-over-quarter.
- 28 funds opened new Core Laboratories positions in Q4 2023 and 19 closed out, a net change of +9 holders.
- The largest Core Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $15.5M added.
- The largest Core Laboratories seller in Q4 2023 was State Farm Mutual Automobile Insurance, an estimated $10.2M sold.
Based on aggregated 13F filings for Q4 2023.